Peripapillary Choroidal Neovascular Membrane Secondary to Sarcoidosis-Related Panuveitis: Treatment with Aflibercept and Ranibizumab with a 50-month Follow-Up

Peripapillary Choroidal Neovascular Membrane Secondary to Sarcoidosis-Related Panuveitis: Treatment with Aflibercept and Ranibizumab with a 50-month Follow-Up

A case of peripapillary choroidal neovascular membrane (PCNM) secondary to sarcoidosis-related panuveitis successfully treated with anti-vascular endothelial growth factor (anti-VEGF) agents and systemic immunomodulatory therapy is reported. Diagnosis and follow-up were based on fundoscopic, optical...

Full description

Bibliographic Details
Main Authors: Artemis Matsou, Maria Dermenoudi, Despina Tzetzi, Tryfon Rotsos, Olga Makri, Eleftherios Anastasopoulos, Chrysanthos Symeonidis
Format: Article
Language:English
Published: Karger Publishers 2021-04-01
Series:Case Reports in Ophthalmology
Subjects:
sarcoidosis
panuveitis
peripapillary choroidal neovascular membrane
anti-vascular endothelial growth factor
aflibercept
ranibizumab
Online Access:https://www.karger.com/Article/FullText/512579

Internet

https://www.karger.com/Article/FullText/512579

Similar Items